(Q28260123)
Statements
A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2 (English)
0 references
15 January 1998
0 references
82
0 references
403-11
0 references
2
0 references